Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RZ-629 in Healthy Subjects and T2D

NCT06829563 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: RZ-629
DRUG: Placebo
OTHER: Fasted
OTHER: Fed

Sponsor

Rezubio Pharmaceuticals Co., Ltd.